|
|
Volumn 434, Issue 7030, 2005, Pages 127-
|
|
Gene-therapy trials to restart following cancer risk review
a
a
NONE
|
|
Author keywords
[No Author keywords available]
|
|
Indexed keywords
ADVISORY COMMITTEE;
CANCER;
CANCER RISK;
COMBINED IMMUNODEFICIENCY;
DISEASE COURSE;
FOOD AND DRUG ADMINISTRATION;
GENE THERAPY;
HUMAN;
NOTE;
PRIORITY JOURNAL;
RISK ASSESSMENT;
SAFETY;
TREATMENT OUTCOME;
UNITED STATES;
X CHROMOSOME LINKED DISORDER;
ARTICLE;
CHILD;
CLINICAL TRIAL;
DISEASE PREDISPOSITION;
FRANCE;
GENETIC LINKAGE;
GENETICS;
NEOPLASM;
STANDARD;
X CHROMOSOME;
CHILD;
CHROMOSOMES, HUMAN, X;
CLINICAL TRIALS;
DISEASE SUSCEPTIBILITY;
FRANCE;
GENE THERAPY;
HUMANS;
LINKAGE (GENETICS);
NEOPLASMS;
SEVERE COMBINED IMMUNODEFICIENCY;
UNITED STATES;
|
|
EID: 15044349631
PISSN: 00280836
EISSN: None
Source Type: Journal
DOI: 10.1038/434127b Document Type: Note |
|
Times cited : (13)
|
|
References (0)
|